Teplizumab, also known as Tzield and made by Sanofi, is approved for children aged 8 and over and adults who have early-stage ...

The immunotherpay can give children and adults three extra years before they need to use insulin.

Interventions reducing or eliminating diabetes medication costs showed variable impacts on adherence, with short-term improvements often diminishing over time. Combining cost-reduction strategies with ...

Teplizumab is an immunotherapy drug designed to modify the immune system's response. Instead of simply treating symptoms, it ...

The landscape of diabetes management is undergoing a remarkable transformation. Groundbreaking research has uncovered surprising cardiovascular benefits tied to modern medications, offering new hope ...

In the United States, over 30 million people suffer from diabetes, while nearly 98 million are classified as pre-diabetic. Unfortunately, rather than addressing the fundamental lifestyle factors that ...

A new and increasingly widely used diabetes medication may have additional health benefits for older adults, according to new research which looked at data from more than 300,000 patients who have ...

A new GLP-1 medication in oral pill form, elecoglipron, could help to significantly reduce blood sugar levels and body weight ...

New research, led by experts at the University of Nottingham, has found that certain types of medication used to treat diabetes may be effective in reducing alcohol use. The study was led by Dr.

Going into 2026, widespread shortages of most major diabetes medications had largely stabilized: The shortages of Humulin and lispro insulin vials, and therefore medications, that dogged ...

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...

Researchers say that GLP-1 drugs like Ozempic used to treat type 2 diabetes may impair a person’s sense of taste and smell.